Group One Trading’s Altamira Therapeutics Ltd CYTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-14
| Closed | -$9 | – | 8194 |
|
|
2024
Q3 | $9 | Hold |
14
| – | – | ﹤0.01% | 6532 |
|
|
2024
Q2 | $16 | Hold |
14
| – | – | ﹤0.01% | 6593 |
|
|
2024
Q1 | $29 | Hold |
14
| – | – | ﹤0.01% | 6882 |
|
|
2023
Q4 | $49 | Sell |
14
-1
| -7% | -$4 | ﹤0.01% | 7232 |
|
|
2023
Q3 | $72 | Hold |
15
| – | – | ﹤0.01% | 7484 |
|
|
2023
Q2 | $191 | Buy |
+15
| New | +$296 | ﹤0.01% | 7475 |
|
|
2023
Q1 | – | Sell |
-37
| Closed | -$3.63K | – | 8184 |
|
|
2022
Q4 | $3.63K | Sell |
37
-125
| -77% | -$14.5K | ﹤0.01% | 6468 |
|
|
2022
Q3 | $19K | Sell |
162
-40
| -20% | -$6.64K | ﹤0.01% | 6113 |
|
|
2022
Q2 | $39K | Buy |
202
+70
| +53% | +$22.6K | ﹤0.01% | 5776 |
|
|
2022
Q1 | $58K | Buy |
132
+3
| +2% | +$1.45K | ﹤0.01% | 5986 |
|
|
2021
Q4 | $94K | Buy |
129
+125
| +3,125% | +$83.8K | ﹤0.01% | 5788 |
|
|
2021
Q3 | $3K | Sell |
4
-46
| -92% | -$51.8K | ﹤0.01% | 7908 |
|
|
2021
Q2 | $71K | Buy |
50
+48
| +2,400% | +$65.9K | ﹤0.01% | 6285 |
|
|
2021
Q1 | $3K | Buy |
+2
| New | +$2.68K | ﹤0.01% | 7357 |
|
|
2017
Q1 | – | Hold |
0
| – | -$4K | – | 5111 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 4161 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 4330 |
|
Other funds holding CYTO
Group One Trading's CYTO Position: Q4 2024 in Review
Group One Trading sold out of Altamira Therapeutics Ltd (CYTO) in Q4 2024, closing a stake of 14 shares — an estimated $9 sold.
Group One Trading first reported a position in CYTO in Q1 2021 and held it in 14 quarters. The position peaked at $94K in Q4 2021. 2 funds tracked by Wall St. Rank hold CYTO as of Q4 2024.
- Group One Trading reported no remaining Altamira Therapeutics Ltd position as of Q4 2024 after selling out during the quarter.
- Group One Trading sold 14 Altamira Therapeutics Ltd shares in Q4 2024, an estimated $9.
- Group One Trading first reported a position in Altamira Therapeutics Ltd in Q1 2021 and held it in 14 quarters.
- Group One Trading's Altamira Therapeutics Ltd position peaked at $94K in Q4 2021.
- 2 funds tracked by Wall St. Rank held Altamira Therapeutics Ltd as of Q4 2024.
Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.